Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-vfjqv Total loading time: 0 Render date: 2024-04-27T05:42:57.937Z Has data issue: false hasContentIssue false

Chapter 18 - Pulmonary vascular pathology

Published online by Cambridge University Press:  05 June 2014

By
Katrien Grünberg  and
Wolter J. Mooi
Edited by
Philip Hasleton  and
Douglas B. Flieder
Philip Hasleton
Affiliation:
University of Manchester
Douglas B. Flieder
Affiliation:
Fox Chase Cancer Center, Philadelphia
Get access

Summary

Introduction

Pulmonary hypertension is defined as a sustained mean pulmonary arterial pressure at rest of ≥ 25 mmHg, i.e., elevated significantly above the upper limit of normal (20 mmHg). Typically, pulmonary arterial pressure increases during exercise. In pulmonary hypertension, this increase is disproportionately high. The pressure is measured by right heart catheterization or can be estimated by echocardiography.

Pulmonary hypertension is a consequence of right ventricular adaptation to increased vascular resistance, increased pulmonary blood flow, or a combination of both. Initially, the symptoms of pulmonary hypertension are nonspecific and usually limited to dyspnea, particularly on exertion, or patients may be asymptomatic. As the pulmonary hypertension progresses, signs and symptoms of right-sided heart failure develop; namely peripheral edema, fatigue, abdominal fullness, angina pectoris and syncope. Depending on its cause, severity and possible treatment options, pulmonary hypertension may lead to death.

Pulmonary hypertension is a feature of a heterogeneous group of disorders which differ in risk factor profile, initiating factors, response to treatment and prognosis (Table 1).4,5 Among the causal factors, left ventricular failure and mitral valve insufficiency are the commonest, followed by chronic thromboembolic disease.6 Globally, there are marked variations in prevalence of some important causes and risk factors, especially sickle cell disease, chronic schistosomiasis and HIV-AIDS.

Type
Chapter
Information
Spencer's Pathology of the Lung , pp. 661 - 710
Publisher: Cambridge University Press
Print publication year: 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Badesch, DB, Champion, HC, Sanchez, MA, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009;54(1 Suppl):S55–66.CrossRefGoogle ScholarPubMed
McLaughlin, VV, Archer, SL, Badesch, DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation 2009;119:2250–94.Google Scholar
McLaughlin, VV, Archer, SL, Badesch, DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009;53(17):1573–619.CrossRefGoogle Scholar
Humbert, M, Nunes, H, Sitbon, O, et al. Risk factors for pulmonary arterial hypertension. Clin Chest Med 2001;22(3):459–75.CrossRefGoogle ScholarPubMed
Galie, N, Torbicki, A, Barst, R, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 2004;25(24):2243–78.Google ScholarPubMed
Hoeper, MM, Barbera, JA, Channick, RN, et al. Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol 2009;54(1 Suppl):S85-S96.CrossRefGoogle ScholarPubMed
Humbert, M, Sitbon, O, Chaouat, A, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 2006;173(9):1023–30.CrossRefGoogle ScholarPubMed
Lapa, MS, Ferreira, EV, Jardim, C, et al. [Clinical characteristics of pulmonary hypertension patients in two reference centers in the city of Sao Paulo]. Rev Assoc Med Bras 2006;52(3):139–43.CrossRefGoogle Scholar
Peacock, AJ, Murphy, NF, McMurray, JJ, Caballero, L, Stewart, S.An epidemiological study of pulmonary arterial hypertension. Eur Respir J 2007;30(1):104–9.CrossRefGoogle ScholarPubMed
Simonneau, G, Galie, N, Rubin, LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004;43(12 Suppl S):5S–12S.CrossRefGoogle ScholarPubMed
Simonneau, G, Robbins, IM, Beghetti, M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009;54(1 Suppl):S43-S54.CrossRefGoogle ScholarPubMed
Wagenvoort, CA, Wagenvoort, N.Pathology of Pulmonary Hypertension. New York: Wiley & Sons, 1977.Google Scholar
Wagenvoort, CA, Mooi, WJ.Biopsy Pathology of the Pulmonary Vasculature. Biopsy and Pathology. Series 13. 1st ed. London: Chapman and Hall Medical, 1989.Google Scholar
van Wolferen, SA, Grünberg, K, Vonk, NA.Diagnosis and management of pulmonary hypertension over the past 100 years. Respir Med 2007;101(3):389–98.CrossRefGoogle ScholarPubMed
Churg, A.An inflation procedure for open lung biopsies. Am J Surg Pathol 1983;7(1):69–71.CrossRefGoogle ScholarPubMed
Gray, H. Gray's Anatomy of the Human Body, 30th ed. Philadelphia: Lea & Febiger, 1985.
Shaw, AM, Bunton, DC, Fisher, A, et al. V-shaped cushion at the origin of bovine pulmonary supernumerary arteries: structure and putative function. J Appl Physiol 1999;87(6):2348–56.CrossRefGoogle ScholarPubMed
Yaginuma, G, Mohri, H, Takahashi, T.Distribution of arterial lesions and collateral pathways in the pulmonary hypertension of congenital heart disease: a computer aided reconstruction study. Thorax 1990;45(8):586–90.CrossRefGoogle ScholarPubMed
Stenmark, KR, Abman, SH.Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia. Annu Rev Physiol 2005;67:623–61.CrossRefGoogle ScholarPubMed
Eddahibi, S, Humbert, M, Fadel, E, et al. Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest 2001;108(8):1141–50.CrossRefGoogle ScholarPubMed
Marcos, E, Fadel, E, Sanchez, O, et al. Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension. Circ Res 2004;94(9):1263–70.CrossRefGoogle ScholarPubMed
Shaw, AM, Bunton, DC, Brown, T, Irvine, J, MacDonald, A.Regulation of sensitivity to 5-hydroxytryptamine in pulmonary supernumerary but not conventional arteries by a 5-HT(1D)-like receptor. Eur J Pharmacol 2000;408(1):69–82.CrossRefGoogle Scholar
Shi, W, Hu, F, Kassouf, W, Michel, RP.Altered reactivity of pulmonary vessels in postobstructive pulmonary vasculopathy. J Appl Physiol 2000;88(1):17–25.CrossRefGoogle ScholarPubMed
Hislop, AA, Pierce, CM.Growth of the vascular tree. Paediatr Respir Rev 2000;1(4):321–7.Google ScholarPubMed
Stenmark, KR, Davie, N, Frid, M, Gerasimovskaya, E, Das, M.Role of the adventitia in pulmonary vascular remodeling. Physiology (Bethesda) 2006;21:134–45.Google ScholarPubMed
Wagenvoort, CA, Wagenvoort, N.Age changes in muscular pulmonary arteries. Arch Pathol 1965;79:524–8.Google ScholarPubMed
Semmens, M.The pulmonary artery in the normal aged lung. Br J Dis Chest 1970;64(2):65–72.CrossRefGoogle ScholarPubMed
Montani, D, Achouh, L, Dorfmuller, P, Le Pavec, J, Sztrymf, B, Tcherakian, C, et al. Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology. Medicine (Baltimore) 2008;87(4):220–33.CrossRefGoogle Scholar
Resten, A, Maitre, S, Humbert, M, et al. Pulmonary arterial hypertension: thin-section CT predictors of epoprostenol therapy failure. Radiology 2002;222(3):782–8.CrossRefGoogle ScholarPubMed
Resten, A, Maitre, S, Humbert, M, et al. Pulmonary hypertension: CT of the chest in pulmonary venoocclusive disease. AJR Am J Roentgenol 2004;183(1):65–70.CrossRefGoogle ScholarPubMed
Deng, Z, Morse, JH, Slager, SL, et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet 2000;67(3):737–44.CrossRefGoogle ScholarPubMed
Aldred, MA, Vijayakrishnan, J, James, V, , S et al. BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension. Hum Mutat 2006;27(2):212–3.CrossRefGoogle ScholarPubMed
Machado, RD, Pauciulo, MW, Thomson, JR, et al. BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. Am J Hum Genet 2001;68(1):92–102.CrossRefGoogle ScholarPubMed
Thomson, JR, Machado, RD, Pauciulo, MW, et al. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family. J Med Genet 2000;37(10):741–5.CrossRefGoogle ScholarPubMed
Humbert, M, Deng, Z, Simonneau, G, et al. BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives. Eur Respir J 2002;20(3):518–23.CrossRefGoogle ScholarPubMed
Souza, R, Humbert, M, Sztrymf, B, et al. Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases. Eur Respir J 2008;31(2):343–8.CrossRefGoogle ScholarPubMed
Sztrymf, B, Coulet, F, Girerd, B, et al. Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation. Am J Respir Crit Care Med 2008;177(12):1377–83.CrossRefGoogle ScholarPubMed
Lang, I.Advances in understanding the pathogenesis of chronic thromboembolic pulmonary hypertension. Br J Haematol 2010;149(4):478–83.CrossRefGoogle ScholarPubMed
Machado, RD, Eickelberg, O, Elliott, CG, et al. Genetics and genomics of pulmonary arterial hypertension. J Am Coll Cardiol 2009;54(1 Suppl):S32-S42.CrossRefGoogle ScholarPubMed
Morrell, NW, Adnot, S, Archer, SL, et al. Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol 2009;54(1 Suppl):S20–31.CrossRefGoogle ScholarPubMed
Rabinovitch, M.Molecular pathogenesis of pulmonary arterial hypertension. J Clin Invest 2008;118:2372–9.CrossRefGoogle ScholarPubMed
Hassoun, PM, Mouthon, L, Barbera, JA, et al. Inflammation, growth factors, and pulmonary vascular remodeling. J Am Coll Cardiol 2009;54(1 Suppl): S10–19.CrossRefGoogle ScholarPubMed
Zhang, S, Fantozzi, I, Tigno, DD, et al. Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2003;285(3):L740–54.CrossRefGoogle ScholarPubMed
Liu, D, Wang, J, Kinzel, B, et al. Dosage-dependent requirement of BMP type II receptor for maintenance of vascular integrity. Blood 2007;110(5):1502–10.CrossRefGoogle ScholarPubMed
Long, L, MacLean, MR, Jeffery, TK, et al. Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice. Circ Res 2006;98(6):818–27.CrossRefGoogle ScholarPubMed
Hong, KH, Lee, YJ, Lee, E, et al. Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension. Circulation 2008;118(7):722–30.CrossRefGoogle ScholarPubMed
Morrell, NW.Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling?Proc Am Thorac Soc 2006;3(8):680–6.CrossRefGoogle ScholarPubMed
Chaouat, A, Coulet, F, Favre, C, et al. Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension. Thorax 2004;59(5):446–8.CrossRefGoogle Scholar
Trembath, RC, Thomson, JR, Machado, RD, et al. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 2001;345(5):325–34.CrossRefGoogle ScholarPubMed
Newman, JH, Trembath, RC, Morse, JA, et al. Genetic basis of pulmonary arterial hypertension: current understanding and future directions. J Am Coll Cardiol 2004;43(12 Suppl S):33S–9S.CrossRefGoogle ScholarPubMed
Roberts, KE, McElroy, JJ, Wong, WP, et al. BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease. Eur Respir J 2004;24(3):371–4.CrossRefGoogle ScholarPubMed
Morse, J, Barst, R, Horn, E, et al. Pulmonary hypertension in scleroderma spectrum of disease: lack of bone morphogenetic protein receptor 2 mutations. J Rheumatol 2002;29(11):2379–81.Google ScholarPubMed
Wipff, J, Kahan, A, Hachulla, E, et al. Association between an endoglin gene polymorphism and systemic sclerosis-related pulmonary arterial hypertension. Rheumatology (Oxford) 2007;46(4):622–5.CrossRefGoogle ScholarPubMed
Hu, H, Sung, A, Zhao, G, Shi, L, Qiu, D, Nishimura, T, et al. Simvastatin enhances bone morphogenetic protein receptor type II expression. Biochem Biophys Res Commun 2006;339(1):59–64.CrossRefGoogle ScholarPubMed
Nishimura, T, Vaszar, LT, Faul, JL, et al. Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells. Circulation 2003;108(13):1640–5.CrossRefGoogle ScholarPubMed
Taraseviciene-Stewart, L, Scerbavicius, R, Choe, KH, et al. Simvastatin causes endothelial cell apoptosis and attenuates severe pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2006;291(4):L668–76.CrossRefGoogle ScholarPubMed
Reynolds, AM, Xia, W, Holmes, MD, et al. Bone morphogenetic protein type 2 receptor gene therapy attenuates hypoxic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2007;292(5):L1182–92.CrossRefGoogle ScholarPubMed
McMurtry, MS, Moudgil, R, Hashimoto, K, et al. Overexpression of human bone morphogenetic protein receptor 2 does not ameliorate monocrotaline pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 2007;292(4):L872–8.CrossRefGoogle Scholar
Lee, SL, Wang, WW, Moore, BJ, Fanburg, BL.Dual effect of serotonin on growth of bovine pulmonary artery smooth muscle cells in culture. Circ Res 1991;68(5):1362–8.CrossRefGoogle ScholarPubMed
Eddahibi, S, Morrell, N, d'Ortho, MP, Naeije, R, Adnot, S.Pathobiology of pulmonary arterial hypertension. Eur Respir J 2002;20(6):1559–72.CrossRefGoogle ScholarPubMed
Eddahibi, S, Chaouat, A, Morrell, N, et al. Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary disease. Circulation 2003;108(15):1839–44.CrossRefGoogle ScholarPubMed
Herve, P, Launay, JM, Scrobohaci, ML, et al. Increased plasma serotonin in primary pulmonary hypertension. Am J Med 1995;99(3):249–54.CrossRefGoogle ScholarPubMed
Taraseviciute, A, Voelkel, NF.Severe pulmonary hypertension in postmenopausal obese women. Eur J Med Res 2006;11(5):198–202.Google ScholarPubMed
Chin, KM, Channick, RN, Rubin, LJ.Is methamphetamine use associated with idiopathic pulmonary arterial hypertension?Chest 2006;130(6):1657–63.CrossRefGoogle ScholarPubMed
van Wolferen, SA, Vonk, NA, Boonstra, A, Postmus, PE.[Pulmonary arterial hypertension due to the use of amphetamines as drugs or doping]. Ned Tijdschr Geneeskd 2005;149(23):1283–8.Google Scholar
Hagen, M, Fagan, K, Steudel, W, et al. Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle. Am J Physiol Lung Cell Mol Physiol 2007;292(6):L1473–9.CrossRefGoogle ScholarPubMed
Ulrich, S, Taraseviciene-Stewart, L, Huber, LC, Speich, R, Voelkel, N.Peripheral blood B lymphocytes derived from patients with idiopathic pulmonary arterial hypertension express a different RNA pattern compared with healthy controls: a cross sectional study. Respir Res 2008;9:20.CrossRefGoogle Scholar
Voelkel, NF, Cool, C.Pathology of pulmonary hypertension. Cardiol Clin 2004;22(3):343–51.CrossRefGoogle ScholarPubMed
Taraseviciene-Stewart, L, Nicolls, MR, Kraskauskas, D, et al. Absence of T cells confers increased pulmonary arterial hypertension and vascular remodeling. Am J Respir Crit Care Med 2007;175(12):1280–9.CrossRefGoogle ScholarPubMed
Lesprit, P, Godeau, B, Authier, FJ, et al. Pulmonary hypertension in POEMS syndrome: a new feature mediated by cytokines. Am J Respir Crit Care Med 1998;157(3 Pt 1):907–11.CrossRefGoogle ScholarPubMed
Riccieri, V, Germano, V, Alessandri, C, et al. More severe nailfold capillaroscopy findings and anti-endothelial cell antibodies. Are they useful tools for prognostic use in systemic sclerosis?Clin Exp Rheumatol 2008;26(6):992–7.Google ScholarPubMed
van Paassen, P, Duijvestijn, A, Brus-Palmans, L, et al. Induction of endothelial cell apoptosis by IgG antibodies from SLE patients with nephropathy: a potential role for anti-endothelial cell antibodies. Ann N Y Acad Sci 2007;1108:147–56.CrossRefGoogle ScholarPubMed
Magro, CM, Ross, P, Marsh, CB, et al. The role of anti-endothelial cell antibody-mediated microvascular injury in the evolution of pulmonary fibrosis in the setting of collagen vascular disease. Am J Clin Pathol 2007;127(2):237–47.CrossRefGoogle ScholarPubMed
Baroni, SS, Santillo, M, Bevilacqua, F, et al. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med 2006;354(25):2667–76.CrossRefGoogle ScholarPubMed
Loizos, N, Lariccia, L, Weiner, J, et al. Lack of detection of agonist activity by antibodies to platelet-derived growth factor receptor alpha in a subset of normal and systemic sclerosis patient sera. Arthritis Rheum 2009;60(4):1145–51.CrossRefGoogle Scholar
Humbert, M, Monti, G, Fartoukh, M, et al. Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients. Eur Respir J 1998;11(3):554–9.Google ScholarPubMed
Overbeek, MJ, Boonstra, A, Voskuyl, AE, et al. Platelet-derived growth factor receptor-beta and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: a case-control study. Arthritis Res Ther 2011;13(2):R61.CrossRefGoogle ScholarPubMed
Classen, JF, Henrohn, D, Rorsman, F, et al. Lack of evidence of stimulatory autoantibodies to platelet-derived growth factor receptor in patients with systemic sclerosis. Arthritis Rheum 2009;60(4):1137–44.CrossRefGoogle ScholarPubMed
Ghofrani, HA, Seeger, W, Grimminger, F.Imatinib for the treatment of pulmonary arterial hypertension. N Engl J Med 2005;353(13):1412–3.CrossRefGoogle ScholarPubMed
Schermuly, RT, Dony, E, Ghofrani, HA, et al. Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 2005;115(10):2811–21.CrossRefGoogle ScholarPubMed
Barst, RJ.PDGF signaling in pulmonary arterial hypertension. J Clin Invest 2005;115(10):2691–4.CrossRefGoogle ScholarPubMed
Patterson, KC, Weissmann, A, Ahmadi, T, Farber, HW.Imatinib mesylate in the treatment of refractory idiopathic pulmonary arterial hypertension. Ann Intern Med 2006;145(2):152–3.CrossRefGoogle ScholarPubMed
Overbeek, MJ, Nieuw Amerongen, GP, Boonstra, A, Smit, EF, Vonk-Noordegraaf, A.Possible role of imatinib in clinical pulmonary veno-occlusive disease. Eur Respir J 2008;32(1):232–5.CrossRefGoogle ScholarPubMed
Daley, E, Emson, C, Guignabert, C, et al. Pulmonary arterial remodeling induced by a Th2 immune response. J Exp Med 2008;205(2):361–72.CrossRefGoogle ScholarPubMed
Sharma, V, Delgado, M, Ganea, D.VIP protects Th2 cells by downregulating granzyme B expression. Ann N Y Acad Sci 2006;1070:540–4.CrossRefGoogle ScholarPubMed
Gonzalez-Rey, E, Chorny, A, Fernandez-Martin, A, Ganea, D, Delgado, M.Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells. Blood 2006;107(9):3632–8.CrossRefGoogle ScholarPubMed
Said, SI, Hamidi, SA, Dickman, KG, et al. Moderate pulmonary arterial hypertension in male mice lacking the vasoactive intestinal peptide gene. Circulation 2007;115(10):1260–8.Google ScholarPubMed
Petkov, V, Mosgoeller, W, Ziesche, R, et al. Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension. J Clin Invest 2003;111(9):1339–46.CrossRefGoogle ScholarPubMed
Barnes, PJ, Liu, SF.Regulation of pulmonary vascular tone. Pharmacol Rev 1995;47(1):87–131.Google ScholarPubMed
Merkus, D, de Beer, V, Houweling, B, Duncker, DJ.Control of pulmonary vascular tone during exercise in health and pulmonary hypertension. Pharmacol Ther 2008;119(3):242–63.CrossRefGoogle ScholarPubMed
Merkus, D, Houweling, B, de Beer, JV, Everon, Z, Duncker, DJ.Alterations in endothelial control of the pulmonary circulation in exercising swine with secondary pulmonary hypertension after myocardial infarction. J Physiol 2007; 580(Pt.3):907–23.CrossRefGoogle ScholarPubMed
Fredenburgh, LE, Liang, OD, Macias, AA, et al. Absence of cyclooxygenase-2 exacerbates hypoxia-induced pulmonary hypertension and enhances contractility of vascular smooth muscle cells. Circulation 2008;117:2114–22.CrossRefGoogle ScholarPubMed
Jernigan, NL, Walker, BR, Resta, TC.Reactive oxygen species mediate RhoA/Rho kinase-induced Ca2+ sensitization in pulmonary vascular smooth muscle following chronic hypoxia. Am J Physiol Lung Cell Mol Physiol 2008;295(3):L515–29.CrossRefGoogle ScholarPubMed
Star, GP, Giovinazzo, M, Langleben, D.Effects of bone morphogenic proteins and transforming growth factor-beta on in-vitro production of endothelin-1 by human pulmonary microvascular endothelial cells. Vascul Pharmacol 2009;50(1–2):45–50.CrossRefGoogle ScholarPubMed
Tang, L, Luo, B, Patel, RP, et al. Modulation of pulmonary endothelial endothelin B receptor expression and signaling: implications for experimental hepatopulmonary syndrome. Am J Physiol Lung Cell Mol Physiol 2007;292(6):L1467–72.CrossRefGoogle ScholarPubMed
Humbert, M, Morrell, NW, Archer, SL, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43(12 Suppl S):13S–24S.CrossRefGoogle ScholarPubMed
Ono, S, Westcott, JY, Voelkel, NF.PAF antagonists inhibit pulmonary vascular remodeling induced by hypobaric hypoxia in rats. J Appl Physiol 1992;73(3):1084–92.CrossRefGoogle ScholarPubMed
McCormack, DG, Barnes, PJ, Evans, TW.Platelet-activating factor: evidence against a role in hypoxic pulmonary vasoconstriction. Crit Care Med 1990;18(12):1398–402.CrossRefGoogle ScholarPubMed
Li, M, Scott, DE, Shandas, R, Stenmark, KR, Tan, W.High pulsatility flow induces adhesion molecule and cytokine mRNA expression in distal pulmonary artery endothelial cells. Ann Biomed Eng 2009;37(6):1082–92.CrossRefGoogle ScholarPubMed
Christman, BW, McPherson, CD, Newman, JH, et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 1992;327(2):70–5.CrossRefGoogle ScholarPubMed
Hoeper, MM, Sosada, M, Fabel, H.Plasma coagulation profiles in patients with severe primary pulmonary hypertension. Eur Respir J 1998;12(6):1446–9.CrossRefGoogle ScholarPubMed
Bakouboula, B, Morel, O, Faure, A, et al. Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension. Am J Respir Crit Care Med 2008;177(5):536–43.CrossRefGoogle ScholarPubMed
Nishimaki, T, Aotsuka, S, Kondo, H, et al. Immunological analysis of pulmonary hypertension in connective tissue diseases. J Rheumatol 1999;26(11):2357–62.Google ScholarPubMed
Okawa-Takatsuji, M, Aotsuka, S, Uwatoko, S, Kinoshita, M, Sumiya, M.Increase of cytokine production by pulmonary artery endothelial cells induced by supernatants from monocytes stimulated with autoantibodies against U1-ribonucleoprotein. Clin Exp Rheumatol 1999;17(6):705–12.Google ScholarPubMed
Dorfmuller, P, Zarka, V, Durand-Gasselin, I, et al. Chemokine RANTES in severe pulmonary arterial hypertension. Am J Respir Crit Care Med 2002;165(4):534–9.CrossRefGoogle ScholarPubMed
Balabanian, K, Foussat, A, Dorfmuller, P, et al. CX(3)C chemokine fractalkine in pulmonary arterial hypertension. Am J Respir Crit Care Med 2002;165(10):1419–25.CrossRefGoogle ScholarPubMed
Marshall, BE, Hanson, CW, Frasch, F, Marshall, C.Role of hypoxic pulmonary vasoconstriction in pulmonary gas exchange and blood flow distribution. 2. Pathophysiology. Intensive Care Med 1994;20(5):379–89.CrossRefGoogle ScholarPubMed
Moudgil, R, Michelakis, ED, Archer, SL.The role of k+ channels in determining pulmonary vascular tone, oxygen sensing, cell proliferation, and apoptosis: implications in hypoxic pulmonary vasoconstriction and pulmonary arterial hypertension. Microcirculation 2006;13(8):615–32.CrossRefGoogle ScholarPubMed
Remillard, CV, Yuan, JX.High altitude pulmonary hypertension: role of K+ and Ca2+ channels. High Alt Med Biol 2005;6(2):133–46.CrossRefGoogle ScholarPubMed
Archer, SL, Gomberg-Maitland, M, Maitland, ML, et al. Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer. Am J Physiol Heart Circ Physiol 2008;294(2):H570–8.CrossRefGoogle ScholarPubMed
Hyvelin, JM, Howell, K, Nichol, A, et al. Inhibition of Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation. Circ Res 2005;97(2):185–91.CrossRefGoogle ScholarPubMed
Li, F, Xia, W, Yuan, S, Sun, R.Acute inhibition of rho-kinase attenuates pulmonary hypertension in patients with congenital heart disease. Pediatr Cardiol 2008 Oct 25.Google Scholar
Bonnet, S, Rochefort, G, Sutendra, G, et al. The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted. Proc Natl Acad Sci U S A 2007;104(27):11418–23.CrossRefGoogle ScholarPubMed
Geraci, MW, Moore, M, Gesell, T, et al. Gene expression patterns in the lungs of patients with primary pulmonary hypertension: a gene microarray analysis. Circ Res 2001;88(6):555–62.CrossRefGoogle ScholarPubMed
Frid, MG, Kale, VA, Stenmark, KR.Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: in vitro analysis. Circ Res 2002;90(11):1189–96.CrossRefGoogle ScholarPubMed
Wagenvoort, CA, Wagenvoort, N.Hypoxic pulmonary vascular lesions in man at high altitude and in patients with chronic respiratory disease. Pathol Microbiol (Basel) 1973;39(3):276–82.Google ScholarPubMed
Stenmark, KR, McMurtry, IF.Vascular remodeling versus vasoconstriction in chronic hypoxic pulmonary hypertension: a time for reappraisal?Circ Res 2005;97(2):95–8.CrossRefGoogle ScholarPubMed
Dingemans, KP, Wagenvoort, CA.Pulmonary arteries and veins in experimental hypoxia. An ultrastructural study. Am J Pathol 1978;93(2):353–68.Google ScholarPubMed
van Suylen, RJ, Aartsen, WM, Smits, JF, Daemen, MJ.Dissociation of pulmonary vascular remodeling and right ventricular pressure in tissue angiotensin-converting enzyme-deficient mice under conditions of chronic alveolar hypoxia. Am J Respir Crit Care Med 2001;163(5):1241–5.CrossRefGoogle ScholarPubMed
van Suylen, RJ, Aartsen, WM, Smits, JF, Daemen, MJ.Dissociation of pulmonary vascular remodeling and right ventricular pressure in tissue angiotensin-converting enzyme-deficient mice under conditions of chronic alveolar hypoxia. Am J Respir Crit Care Med 2001;163(5):1241–5.CrossRefGoogle ScholarPubMed
Davie, NJ, Gerasimovskaya, EV, Hofmeister, SE, et al. Pulmonary artery adventitial fibroblasts cooperate with vasa vasorum endothelial cells to regulate vasa vasorum neovascularization: a process mediated by hypoxia and endothelin-1. Am J Pathol 2006;168(6):1793–807.CrossRefGoogle ScholarPubMed
Frid, MG, Brunetti, JA, Burke, DL, et al. Circulating mononuclear cells with a dual, macrophage-fibroblast phenotype contribute robustly to hypoxia-induced pulmonary adventitial remodeling. Chest 2005;128(6 Suppl):583S–4S.CrossRefGoogle ScholarPubMed
Frid, MG, Brunetti, JA, Burke, DL, et al. Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. Am J Pathol 2006;168(2):659–69.CrossRefGoogle ScholarPubMed
Short, M, Nemenoff, RA, Zawada, WM, Stenmark, KR, Das, M.Hypoxia induces differentiation of pulmonary artery adventitial fibroblasts into myofibroblasts. Am J Physiol Cell Physiol 2004;286(2):C416–25.CrossRefGoogle ScholarPubMed
Davie, NJ, Crossno, JT, Frid, MG, et al. Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization: contribution of progenitor cells. Am J Physiol Lung Cell Mol Physiol 2004;286(4):L668–78.CrossRefGoogle ScholarPubMed
Wagenvoort, CA.Lung biopsy findings in secondary pulmonary hypertension. Heart Lung 1986;15(5):429–50.Google ScholarPubMed
Shehata, SM, Sharma, HS, van der Staak, FH, et al. Remodeling of pulmonary arteries in human congenital diaphragmatic hernia with or without extracorporeal membrane oxygenation. J Pediatr Surg 2000;35(2):208–15.CrossRefGoogle ScholarPubMed
Galie, N, Manes, A, Farahani, KV, et al. Pulmonary arterial hypertension associated to connective tissue diseases. Lupus 2005;14(9):713–7.CrossRefGoogle ScholarPubMed
Wagenvoort, CA.Morphological substrate for the reversibility and irreversibility of pulmonary hypertension. Eur Heart J 1988;9 Suppl J:7–12.CrossRefGoogle ScholarPubMed
Wagenvoort, CA.Open lung biopsies in congenital heart disease for evaluation of pulmonary vascular disease. Predictive value with regard to corrective operability. Histopathology 1985;9(4):417–36.CrossRefGoogle ScholarPubMed
Chaves, E.Changes in media and intima of pulmonary vessels in schistosomal cor pulmonale (10 cases). Br Heart J 1966;28(5):599–601.CrossRefGoogle Scholar
Chaves, E.The pathology of the arterial pulmonary vasculature in manson's schistosomiasis. Dis Chest 1966;50(1):72–7.CrossRefGoogle ScholarPubMed
Chaves, E.Necrotizing and healing pulmonary arteritis in schistosomal cor pulmonale: a retrospective study of ten cases. Am J Trop Med Hyg 1966;15(2):162–7.CrossRefGoogle ScholarPubMed
Pozzan, G.Histopathological features of pulmonary vascular disease in chronic schistosoma mansoni infection are not different from those in idiopathic pulmonary hypertension (PH). Am J Respir Crit Care Med 2008;177:A443.Google Scholar
Hall, SM, Haworth, SG.Onset and evolution of pulmonary vascular disease in young children: abnormal postnatal remodelling studied in lung biopsies. J Pathol 1992;166(2):183–93.CrossRefGoogle ScholarPubMed
Wagenvoort, CA, Wagenvoort, N.Pathology of the Eisenmenger syndrome and primary pulmonary hypertension. Adv Cardiol 1974;11(00):123–30.CrossRefGoogle ScholarPubMed
Heath, D, Smith, P, Gosney, J, et al. The pathology of the early and late stages of primary pulmonary hypertension. Br Heart J 1987;58(3):204–13.CrossRefGoogle ScholarPubMed
Balk, AG, Dingemans, KP, Wagenvoort, CA.The ultrastructure of the various forms of pulmonary arterial intimal fibrosis. Virchows Arch A Pathol Anat Histol 1979;382(2):139–50.CrossRefGoogle Scholar
Smith, P, Heath, D, Yacoub, M, et al. The ultrastructure of plexogenic pulmonary arteriopathy. J Pathol 1990;160(2):111–21.CrossRefGoogle ScholarPubMed
Mitchell, RN, Libby, P.Vascular remodeling in transplant vasculopathy. Circ Res 2007;100(7):967–78.CrossRefGoogle ScholarPubMed
Wagenvoort, CA, Nauta, J, van der Schaar, PJ, Weeda, HW, Wagenvoort, N.Effect of flow and pressure on pulmonary vessels. A semiquantitative study based on lung biopsies. Circulation 1967;35(6):1028–37.CrossRefGoogle ScholarPubMed
Wagenvoort, CA.Pathology of the pulmonary vasculature. Correlation with clinical and haemodynamic data. Schweiz Med Wochenschr 1985;115(39):1319–22.Google ScholarPubMed
Yamaki, S, Wagenvoort, CA.Comparison of primary plexogenic arteriopathy in adults and children. A morphometric study in 40 patients. Br Heart J 1985;54(4):428–34.CrossRefGoogle ScholarPubMed
Wagenvoort, CA, Mulder, PG.Thrombotic lesions in primary plexogenic arteriopathy. Similar pathogenesis or complication?Chest 1993;103(3):844–9.CrossRefGoogle ScholarPubMed
Overbeek, MJ, Vonk, MC, Boonstra, A, et al. Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy. Eur Respir J 2009;34(2):371–9.CrossRefGoogle ScholarPubMed
Hyvelin, JM, Gautier, M, Lemaire, MC, Bonnet, P, Eder, V. Adaptative modifications of right coronary myocytes voltage-gated K(+) currents in rat with hypoxic pulmonary hypertension. Pflugers Arch 2009;457(4): 721–30.CrossRef
Moschcowitz, E, Rubin, E, Strauss, L.Hypertension of the pulmonary circulation due to congenital glomoid obstruction of the pulmonary arteries. Am J Pathol 1961;39:75–93.Google ScholarPubMed
Yi, ES, Kim, H, Ahn, H, et al. Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension. A morphometric and immunohistochemical study. Am J Respir Crit Care Med 2000;162(4 Pt 1):1577–86.CrossRefGoogle ScholarPubMed
Smith, P, Heath, D.Electron microscopy of the plexiform lesion. Thorax 1979;34(2):177–86.CrossRefGoogle ScholarPubMed
Heath, D, Edwards, JE.The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation 1958;18(4 Part 1):533–47.CrossRefGoogle ScholarPubMed
Tuder, RM, Chacon, M, Alger, L, et al. Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis. J Pathol 2001;195(3):367–74.CrossRefGoogle ScholarPubMed
Hirose, S, Hosoda, Y, Furuya, S, Otsuki, T, Ikeda, E.Expression of vascular endothelial growth factor and its receptors correlates closely with formation of the plexiform lesion in human pulmonary hypertension. Pathol Int 2000;50(6):472–9.CrossRefGoogle ScholarPubMed
Cool, CD, Stewart, JS, Werahera, P, et al. Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth. Am J Pathol 1999;155(2):411–9.CrossRefGoogle ScholarPubMed
Geiger, R, Berger, RM, Hess, J, et al. Enhanced expression of vascular endothelial growth factor in pulmonary plexogenic arteriopathy due to congenital heart disease. J Pathol 2000;191(2):202–7.3.0.CO;2-D>CrossRefGoogle ScholarPubMed
Taraseviciene-Stewart, L, Kasahara, Y, Alger, L, et al. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB J 2001;15(2):427–38.CrossRefGoogle ScholarPubMed
Sakao, S, Taraseviciene-Stewart, L, Lee, JD, et al. Initial apoptosis is followed by increased proliferation of apoptosis-resistant endothelial cells. FASEB J 2005;19(9):1178–80.CrossRefGoogle ScholarPubMed
Cool, CD, Rai, PR, Yeager, ME, et al. Expression of human herpesvirus 8 in primary pulmonary hypertension. N Engl J Med 2003;349(12):1113–22.CrossRefGoogle ScholarPubMed
Bull, TM, Cool, CD, Serls, AE, et al. Primary pulmonary hypertension, Castleman's disease and human herpesvirus-8. Eur Respir J 2003;22(3):403–7.CrossRefGoogle ScholarPubMed
Bendayan, D, Sarid, R, Cohen, A, et al. Absence of human herpesvirus 8 DNA sequences in lung biopsies from Israeli patients with pulmonary arterial hypertension. Respiration 2008;75(2):155–7.CrossRefGoogle ScholarPubMed
Bresser, P, Cornelissen, MI, , BW, van Noesel, CJ, Timens, W.Idiopathic pulmonary arterial hypertension in Dutch Caucasian patients is not associated with human herpes virus-8 infection. Respir Med 2007;101(4):854–6.CrossRefGoogle Scholar
Galambos, C, Montgomery, J, Jenkins, FJ.No role for kaposi sarcoma-associated herpesvirus in pediatric idiopathic pulmonary hypertension. Pediatr Pulmonol 2006;41(2):122–5.CrossRefGoogle ScholarPubMed
Henke-Gendo, C, Mengel, M, Hoeper, MM, Alkharsah, K, Schulz, TF.Absence of Kaposi's sarcoma-associated herpesvirus in patients with pulmonary arterial hypertension. Am J Respir Crit Care Med 2005;172(12):1581–5.CrossRefGoogle ScholarPubMed
Katano, H, Ito, K, Shibuya, K, et al. Lack of human herpesvirus 8 infection in lungs of Japanese patients with primary pulmonary hypertension. J Infect Dis 2005;191(5):743–5.CrossRefGoogle ScholarPubMed
Daibata, M, Miyoshi, I, Taguchi, H, et al. Absence of human herpesvirus 8 in lung tissues from Japanese patients with primary pulmonary hypertension. Respir Med 2004;98(12):1231–2.CrossRefGoogle ScholarPubMed
Higenbottam, T, Wheeldon, D, Wells, F, Wallwork, J.Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin). Lancet 1984;1(8385):1046–7.CrossRefGoogle Scholar
Achcar, RO, Yung, GL, Saffer, H, et al. Morphologic changes in explanted lungs after prostacyclin therapy for pulmonary hypertension. Eur J Med Res 2006;11(5):203–7.Google ScholarPubMed
Bonderman, D, Skoro-Sajer, N, Jakowitsch, J, et al. Predictors of outcome in chronic thromboembolic pulmonary hypertension. Circulation 2007;115(16):2153–8.CrossRefGoogle ScholarPubMed
Pengo, V, Lensing, AW, Prins, MH, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004;350(22):2257–64.CrossRefGoogle ScholarPubMed
Douketis, JD, Gu, CS, Schulman, S, et al. The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism. Ann Intern Med 2007;147(11):766–74.CrossRefGoogle ScholarPubMed
Schulman, S, Ogren, M.New concepts in optimal management of anticoagulant therapy for extended treatment of venous thromboembolism. Thromb Haemost 2006;96(3):258–66.Google ScholarPubMed
Bonderman, D, Wilkens, H, Wakounig, S, Schafers, HJ, Jansa, P, Lindner, J, et al. Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J 2009;33(2):325–31.CrossRefGoogle ScholarPubMed
Bonderman, D, Jakowitsch, J, Adlbrecht, C, et al. Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension. Thromb Haemost 2005;93(3):512–6.Google ScholarPubMed
Chew, HK, Davies, AM, Wun, T, et al. The incidence of venous thromboembolism among patients with primary lung cancer. J Thromb Haemost 2008;6(4):601–8.CrossRefGoogle ScholarPubMed
Trujillo-Santos, J, Prandoni, P, Rivron-Guillot, K, et al. Clinical outcome in patients with venous thromboembolism and hidden cancer: findings from the RIETE Registry. J Thromb Haemost 2008;6(2):251–5.CrossRefGoogle ScholarPubMed
Bernard, J, Yi, ES.Pulmonary thromboendarterectomy: a clinicopathologic study of 200 consecutive pulmonary thromboendarterectomy cases in one institution. Hum Pathol 2007;38(6):871–7.CrossRefGoogle ScholarPubMed
Bonderman, D, Jakowitsch, J, Redwan, B, et al. Role for staphylococci in misguided thrombus resolution of chronic thromboembolic pulmonary hypertension. Arterioscler Thromb Vasc Biol 2008;28(4):678–84.CrossRefGoogle ScholarPubMed
Castro, O, Hoque, M, Brown, BD.Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival. Blood 2003;101(4):1257–61.CrossRefGoogle Scholar
Powars, DR, Chan, LS, Hiti, A, Ramicone, E, Johnson, C.Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine (Baltimore) 2005;84(6):363–76.CrossRefGoogle ScholarPubMed
Franchini, M, Veneri, D, Salvagno, GL, Manzato, F, Lippi, G.Inherited thrombophilia. Crit Rev Clin Lab Sci 2006;43(3):249–90.CrossRefGoogle ScholarPubMed
Brilakis, ES, Manginas, AN, Cokkinos, DV.Chronic thromboembolic pulmonary hypertension in a patient heterozygous for both factor V Leiden and G20210 prothrombin mutation. Heart 2001;86(2):149.CrossRefGoogle Scholar
Hoeper, MM, Niedermeyer, J, Hoffmeyer, F, Flemming, P, Fabel, H.Pulmonary hypertension after splenectomy?Ann Intern Med 1999;130(6):506–9.CrossRefGoogle ScholarPubMed
Atichartakarn, V, Likittanasombat, K, Chuncharunee, S, et al. Pulmonary arterial hypertension in previously splenectomized patients with beta-thalassemic disorders. Int J Hematol 2003;78(2):139–45.CrossRefGoogle ScholarPubMed
Esmon, CT.Basic mechanisms and pathogenesis of venous thrombosis. Blood Rev 2009;23(5):225–9.CrossRefGoogle ScholarPubMed
Elliott, CG, Leppert, MF, Alexander, GJ, et al. Factor V Leiden is not common in patients diagnosed with primary pulmonary hypertension. Eur Respir J 1998;12(5):1177–80.CrossRefGoogle Scholar
Segers, K, Dahlback, B, Nicolaes, GA.Coagulation factor V and thrombophilia: background and mechanisms. Thromb Haemost 2007;98(3):530–42.CrossRefGoogle ScholarPubMed
Kato, GJ, Hebbel, RP, Steinberg, MH, Gladwin, MT.Vasculopathy in sickle cell disease: biology, pathophysiology, genetics, translational medicine, and new research directions. Am J Hematol 2009;84(9):618–25.CrossRefGoogle ScholarPubMed
Gladwin, MT, Sachdev, V, Jison, ML, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 2004;350(9):886–95.CrossRefGoogle ScholarPubMed
De Castro, LM, Jonassaint, JC, Graham, FL, Shley-Koch, A, Telen, MJ.Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes. Am J Hematol 2008;83(1):19–25.CrossRefGoogle ScholarPubMed
Ataga, KI, Moore, CG, Jones, S, et al. Pulmonary hypertension in patients with sickle cell disease: a longitudinal study. Br J Haematol 2006;134(1):109–15.CrossRefGoogle ScholarPubMed
Kark, JA, Posey, DM, Schumacher, HR, Ruehle, CJ.Sickle-cell trait as a risk factor for sudden death in physical training. N Engl J Med 1987;317(13):781–7.CrossRefGoogle ScholarPubMed
Biedrzycki, O, Gillespie, H, Lucas, S.Sudden death in a patient newly diagnosed with diabetes having hyperosmolar non-ketotic acidosis with sickle cell trait. J Clin Pathol 2006;59(8):882–3.CrossRefGoogle Scholar
Minter, KR, Gladwin, MT.Pulmonary complications of sickle cell anemia. A need for increased recognition, treatment, and research. Am J Respir Crit Care Med 2001;164(11):2016–9.CrossRefGoogle Scholar
Barrett-Connor, E.Bacterial infection and sickle cell anemia. An analysis of 250 infections in 166 patients and a review of the literature. Medicine (Baltimore) 1971;50(2):97–112.CrossRefGoogle Scholar
Bromberg, PA.Pulmonary aspects of sickle cell disease. Arch Intern Med 1974;133:652–7.CrossRefGoogle Scholar
Platt, OS.The acute chest syndrome of sickle cell disease. N Engl J Med 2000;342(25):1904–7.CrossRefGoogle ScholarPubMed
Vichinsky, EP, Neumayr, LD, Earles, AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med 2000;342(25):1855–65.CrossRefGoogle ScholarPubMed
Oppenheimer, EH, Esterly, JR.Pulmonary changes in sickle cell disease. Am Rev Respir Dis 1971;103(6):858–9.Google ScholarPubMed
Powars, D, Weidman, JA, Odom-Maryon, T, Niland, JC, Johnson, C.Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure. Medicine (Baltimore) 1988;67(1):66–76.CrossRefGoogle ScholarPubMed
Gladwin, MT, Vichinsky, E.Pulmonary complications of sickle cell disease. N Engl J Med 2008;359(21):2254–65.CrossRefGoogle ScholarPubMed
Morris, CR. Mechanisms of vasculopathy in sickle cell disease and thalassemia. Hematology Am Soc Hematol Educ Program 2008;177–85.
Rees, DC, Williams, TN, Gladwin, MT.Sickle-cell disease. Lancet 2010;376(9757):2018–31.CrossRefGoogle ScholarPubMed
Shimizu, H, Tanabe, N, Terada, J, et al. Dilatation of bronchial arteries correlates with extent of central disease in patients with chronic thromboembolic pulmonary hypertension. Circ J 2008;72(7):1136–41.CrossRefGoogle ScholarPubMed
Ley, S, Kreitner, KF, Morgenstern, I, Thelen, M, Kauczor, HU.Bronchopulmonary shunts in patients with chronic thromboembolic pulmonary hypertension: evaluation with helical CT and MR imaging. AJR Am J Roentgenol 2002;179(5):1209–15.CrossRefGoogle ScholarPubMed
Remy-Jardin, M, Duhamel, A, Deken, V, et al. Systemic collateral supply in patients with chronic thromboembolic and primary pulmonary hypertension: assessment with multi-detector row helical CT angiography. Radiology 2005;235(1):274–81.CrossRefGoogle ScholarPubMed
Wagenvoort, CA.Pathology of pulmonary thromboembolism. Chest 1995;107(1 Suppl):10S–7S.CrossRefGoogle ScholarPubMed
Irniger, W.Histologische altersbestimmung von Thrombosen und Embolien. Virchows Arch Pathol Anat 1963;336:220–37.CrossRefGoogle Scholar
Moser, KM, Bloor, CM.Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest 1993;103(3):685–92.CrossRefGoogle ScholarPubMed
Havig, O.Deep vein thrombosis and pulmonary embolism. An autopsy study with multiple regression analysis of possible risk factors. Acta Chir Scand Suppl 1977;478:1–120.Google ScholarPubMed
Dalen, JE, Haffajee, CI, Alpert, JS, et al. Pulmonary embolism, pulmonary hemorrhage and pulmonary infarction. N Engl J Med 1977;296(25):1431–5.CrossRefGoogle ScholarPubMed
Jaffe, RB, Koschmann, EB.Septic pulmonary emboli. Radiology 1970;96(3):527–32.CrossRefGoogle ScholarPubMed
Redline, S, Tomashefski, JF, Altose, MD.Cavitating lung infarction after bland pulmonary thromboembolism in patients with the adult respiratory distress syndrome. Thorax 1985;40(12):915–9.CrossRefGoogle ScholarPubMed
Hotez, PJ, Bundy, DA P, Beegle, K, et al. Helminth infections: soil-transmitted helminth infections and schistosomiasis. In Jamison, DT, Breman, JG, Measham, AR, et al., eds. Disease Control Priorities in Developing Countries, 2nd ed. Washington DC: World Bank, 2006.Google ScholarPubMed
Hildebrand, FL, Rosenow, EC, Habermann, TM, Tazelaar, HD.Pulmonary complications of leukemia. Chest 1990;98(5):1233–9.CrossRefGoogle ScholarPubMed
Dingli, D, Utz, JP, Krowka, MJ, Oberg, AL, Tefferi, A.Unexplained pulmonary hypertension in chronic myeloproliferative disorders. Chest 2001;120(3):801–8.CrossRefGoogle ScholarPubMed
Steensma, DP, Hook, CC, Stafford, SL, Tefferi, A.Low-dose, single-fraction, whole-lung radiotherapy for pulmonary hypertension associated with myelofibrosis with myeloid metaplasia. Br J Haematol 2002;118(3):813–6.CrossRefGoogle ScholarPubMed
Heath, D, Smith, P, Rios, DJ, Williams, D, Harris, P.Small pulmonary arteries in some natives of La Paz, Bolivia. Thorax 1981;36(8):599–604.CrossRefGoogle ScholarPubMed
Arias-Stella, J, Kruger, H, Recavarren, S.Pathology of chronic mountain sickness. Thorax 1973;28(6):701–8.CrossRefGoogle ScholarPubMed
Wilkinson, M, Langhorne, CA, Heath, D, Barer, GR, Howard, P.A pathophysiological study of 10 cases of hypoxic cor pulmonale. Q J Med 1988;66(249):65–85.Google ScholarPubMed
Girgis, RE, Mathai, SC.Pulmonary hypertension associated with chronic respiratory disease. Clin Chest Med 2007;28(1):219–32.CrossRefGoogle ScholarPubMed
Hasleton, PS, Heath, D, Brewer, DB.Hypertensive pulmonary vascular disease in states of chronic hypoxia. J Pathol Bacteriol 1968;95(2):431–40.CrossRefGoogle ScholarPubMed
Wagenvoort, CA, Keutel, J, Mooi, WJ, Wagenvoort, N.Longitudinal smooth muscle in pulmonary arteries. Occurrence in congenital heart disease. Virchows Arch A Pathol Anat Histopathol 1984;404(3):265–74.CrossRefGoogle ScholarPubMed
Heath, D, Whitaker, W.The pulmonary vessels in mitral stenosis. J Pathol Bacteriol 1955;70(2):291–8.CrossRefGoogle ScholarPubMed
Heath, D, Edwards, JE.Histological changes in the lung in diseases associated with pulmonary venous hypertension. Br J Dis Chest 1959;53(1):8–18.CrossRefGoogle ScholarPubMed
Pai, U, McMahon, J, Tomashefski, JF. Mineralizing pulmonary elastosis in chronic cardiac failure. “Endogenous pneumoconiosis” revisited. Am J Clin Pathol 1994;101(1):22–8.CrossRefGoogle ScholarPubMed
Holcomb, BW, Loyd, JE, Ely, EW, Johnson, J, Robbins, IM.Pulmonary veno-occlusive disease: a case series and new observations. Chest 2000;118(6):1671–9.Google ScholarPubMed
Hora, J.Zur Histologie der Klinischen “primaren Pulmonalsklerose”. Frankf Z Pathol 1934;47:100–18.Google Scholar
Heath, D, Segel, N, Bishop, J.Pulmonary veno-occlusive disease. Circulation 1966;34(2):242–8.CrossRefGoogle ScholarPubMed
Wagenvoort, CA, Beetstra, A, Spijker, J.Capillary haemangiomatosis of the lungs. Histopathology 1978;2(6):401–6.CrossRefGoogle ScholarPubMed
de Perrot, M, Waddell, TK, Chamberlain, D, Hutcheon, M, Keshavjee, S.De novo pulmonary capillary hemangiomatosis occurring rapidly after bilateral lung transplantation. J Heart Lung Transplant 2003;22(6):698–700.CrossRefGoogle ScholarPubMed
Umezu, H, Naito, M, Yagisawa, K, Hattori, A, Aizawa, Y.An autopsy case of pulmonary capillary hemangiomatosis without evidence of pulmonary hypertension. Virchows Arch 2001;439(4):586–92.CrossRefGoogle ScholarPubMed
Sullivan, A, Chmura, K, Cool, CD, Voelkel, N, Chan, ED.Pulmonary capillary hemangiomatosis: an immunohistochemical analysis of vascular remodeling in a fatal case. Chest 2005;128(6 Suppl):576S.CrossRefGoogle Scholar
Humbert, M, Maitre, S, Capron, F, et al. Pulmonary edema complicating continuous intravenous prostacyclin in pulmonary capillary hemangiomatosis. Am J Respir Crit Care Med 1998;157(5 Pt 1):1681–5.CrossRefGoogle ScholarPubMed
Frazier, AA, Franks, TJ, Mohammed, TL, Ozbudak, IH, Galvin, JR.From the Archives of the AFIP: pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis. Radiographics 2007;27(3):867–82.CrossRefGoogle ScholarPubMed
Lantuejoul, S, Sheppard, MN, Corrin, B, Burke, MM, Nicholson, AG.Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis: a clinicopathologic study of 35 cases. Am J Surg Pathol 2006;30(7):850–7.CrossRefGoogle ScholarPubMed
Montani, D, Price, LC, Dorfmuller, P, et al. Pulmonary veno-occlusive disease. Eur Respir J 2009;33(1):189–200.CrossRefGoogle ScholarPubMed
Wagenvoort, CA, Wagenvoort, N, Takahashi, T.Pulmonary veno-occlusive disease: involvement of pulmonary arteries and review of the literature. Hum Pathol 1985;16(10):1033–41.CrossRefGoogle ScholarPubMed
Swift, GL, Gibbs, A, Campbell, IA, Wagenvoort, CA, Tuthill, D.Pulmonary veno-occlusive disease and Hodgkin's lymphoma. Eur Respir J 1993;6(4):596–8.Google ScholarPubMed
Joselson, R, Warnock, M.Pulmonary veno-occlusive disease after chemotherapy. Hum Pathol 1983;14(1):88–91.CrossRefGoogle ScholarPubMed
Steward, CG, Pellier, I, Mahajan, A, t al. Severe pulmonary hypertension: a frequent complication of stem cell transplantation for malignant infantile osteopetrosis. Br J Haematol 2004;124(1):63–71.CrossRefGoogle ScholarPubMed
Seguchi, M, Hirabayashi, N, Fujii, Y, et al. Pulmonary hypertension associated with pulmonary occlusive vasculopathy after allogeneic bone marrow transplantation. Transplantation 2000;69(1):177–9.CrossRefGoogle ScholarPubMed
Trobaugh-Lotrario, AD, Greffe, B, Deterding, R, Deutsch, G, Quinones, R.Pulmonary veno-occlusive disease after autologous bone marrow transplant in a child with stage IV neuroblastoma: case report and literature review. J Pediatr Hematol Oncol 2003;25(5):405–9.CrossRefGoogle Scholar
de Perrot, M, Waddell, TK, Chamberlain, D, Hutcheon, M, Keshavjee, S.De novo pulmonary capillary hemangiomatosis occurring rapidly after bilateral lung transplantation. J Heart Lung Transplant 2003;22(6):698–700.CrossRefGoogle ScholarPubMed
Izbicki, G, Shitrit, D, Schechtman, I, et al. Recurrence of pulmonary veno-occlusive disease after heart-lung transplantation. J Heart Lung Transplant 2005;24(5):635–7.CrossRefGoogle ScholarPubMed
Dwyer, N, Smith, R, Challis, D, Reid, D, Kilpatrick, D.Granulomatous angiitis leading to a pulmonary veno-occlusive disease-like picture. Eur Respir J 2009;33(3):666–9.CrossRefGoogle ScholarPubMed
Langleben, D, Heneghan, JM, Batten, AP, et al. Familial pulmonary capillary hemangiomatosis resulting in primary pulmonary hypertension. Ann Intern Med 1988;109(2):106–9.CrossRefGoogle ScholarPubMed
Montani, D, Jais, X, Price, LC, et al. Cautious use of epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease. Eur Respir J 2009;34:1348–56.CrossRefGoogle ScholarPubMed
Souza, R, Sitbon, O, Parent, F, Simonneau, G, Humbert, M.Long term imatinib treatment in pulmonary arterial hypertension. Thorax 2006;61(8):736.CrossRefGoogle ScholarPubMed
Lee, C, Suh, RD, Krishnam, MS, et al. Recurrent pulmonary capillary hemangiomatosis after bilateral lung transplantation. J Thorac Imaging 2010;25(3):W89–92.CrossRefGoogle ScholarPubMed
Dufour, B, Maitre, S, Humbert, M, et al. High-resolution CT of the chest in four patients with pulmonary capillary hemangiomatosis or pulmonary venoocclusive disease. AJR Am J Roentgenol 1998;171(5):1321–4.CrossRefGoogle ScholarPubMed
Frazier, AA, Franks, TJ, Mohammed, TL, Ozbudak, IH, Galvin, JR.From the Archives of the AFIP: pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis. Radiographics 2007;27(3):867–82.CrossRefGoogle ScholarPubMed
Cool, CD, Kennedy, D, Voelkel, NF, Tuder, RM.Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection. Hum Pathol 1997;28(4):434–42.CrossRefGoogle ScholarPubMed
Wagenaar, SS, Mulder, JJ, Wagenvoort, CA, van den Bosch, JM.Pulmonary capillary haemangiomatosis diagnosed during life. Histopathology 1989;14(2):212–4.CrossRefGoogle ScholarPubMed
Wagenvoort, CA, Wagenvoort, N.The pathology of pulmonary veno-occlusive disease. Virchows Arch A Pathol Anat Histol 1974;364(1):69–79.CrossRefGoogle ScholarPubMed
Pietra, GG, Capron, F, Stewart, S, et al. Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol 2004;43(12 Suppl S):25S–32S.CrossRefGoogle ScholarPubMed
Erbersdobler, A, Niendorf, A.Multifocal distribution of pulmonary capillary haemangiomatosis. Histopathology 2002;40(1):88–91.CrossRefGoogle ScholarPubMed
Dorfmuller, P, Humbert, M, Perros, F, et al. Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. Hum Pathol 2007;38(6):893–902.CrossRefGoogle ScholarPubMed
Abramson, LP, Gerber, S, Chen, YH, Crawford, SE.Fetal constrictive pericardial defect with pulmonary capillary hemangiomatosis. J Pediatr Surg 2002;37(10):1512–4.CrossRefGoogle ScholarPubMed
Jing, X, Yokoi, T, Nakamura, Y, et al. Pulmonary capillary hemangiomatosis: a unique feature of congestive vasculopathy associated with hypertrophic cardiomyopathy. Arch Pathol Lab Med 1998;122(1):94–6.Google ScholarPubMed
Wagenvoort, CA.Classification of pulmonary vascular lesions in congenital and acquired heart disease. Adv Cardiol 1974;11(00):48–55.CrossRefGoogle ScholarPubMed
Wagenvoort, CA, Neufeld, HN, Dushane, JW, Edwards, JE.The pulmonary arterial tree in ventricular septal defect. A quantitative study of anatomic features in fetuses, infants. and children. Circulation 1961;23:740–8.CrossRefGoogle ScholarPubMed
Wagenvoort, CA.The pulmonary arteries in infants with ventricular septal defect. Med Thorac 1962;19:354–61.Google ScholarPubMed
Wagenvoort, CA, Nauta, J, van der Schaar, PJ, Weeda, HW, Wagenvoort, N.Vascular changes in pulmonic stenosis and tetralogy of Fallot studied in lung biopsies. Circulation 1967;36(6):924–32.CrossRefGoogle ScholarPubMed
Young, D, Mark, H.Fate of the patient with the Eisenmenger syndrome. Am J Cardiol 1971;28(6):658–69.CrossRefGoogle ScholarPubMed
Wagenvoort, CA.Lung biopsy specimens in the evaluation of pulmonary vascular disease. Chest 1980;77(5):614–25.CrossRefGoogle ScholarPubMed
Wagenvoort, CA.Grading of pulmonary vascular lesions – a reappraisal. Histopathology 1981;5(6):595–8.CrossRefGoogle ScholarPubMed
Wagenvoort, CA.Grading of pulmonary hypertension. Am J Cardiol 1987;60(10):943.CrossRefGoogle ScholarPubMed
Launay, D, Hachulla, E, Hatron, PY, et al. Pulmonary arterial hypertension: a rare complication of primary Sjögren syndrome: report of 9 new cases and review of the literature. Medicine (Baltimore) 2007;86(5):299–315.CrossRefGoogle ScholarPubMed
Tansey, D, Wells, AU, Colby, TV, et al. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology 2004;44(6):585–96.CrossRefGoogle ScholarPubMed
Magro, CM, Ross, P, Marsh, CB, et al. The role of anti-endothelial cell antibody-mediated microvascular injury in the evolution of pulmonary fibrosis in the setting of collagen vascular disease. Am J Clin Pathol 2007;127(2):237–47.CrossRefGoogle ScholarPubMed
Ostrowski, RA, Robinson, JA.Antiphospholipid antibody syndrome and autoimmune diseases. Hematol Oncol Clin North Am 2008;22(1):53–65, vi.CrossRefGoogle ScholarPubMed
Tanaseanu, C, Tudor, S, Tamsulea, I, et al. Vascular endothelial growth factor, lipoporotein-associated phospholipase A2, sP-selectin and antiphospholipid antibodies, biological markers with prognostic value in pulmonary hypertension associated with chronic obstructive pulmonary disease and systemic lupus erithematosus. Eur J Med Res 2007;12(4):145–51.Google ScholarPubMed
Overbeek, MJ, Lankhaar, JW, Westerhof, N, et al. Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. Eur Respir J 2008;31(6):1160–6.CrossRefGoogle ScholarPubMed
Badui, E, Garcia-Rubi, D, Robles, E, et al. Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients. Angiology 1985;36(7):431–41.CrossRefGoogle ScholarPubMed
Mathai, SC, Hummers, LK, Champion, HC, et al. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: Impact of interstitial lung disease. Arthritis Rheum 2009;60(2):569–77.CrossRefGoogle ScholarPubMed
Young, RH, Mark, GJ.Pulmonary vascular changes in scleroderma. Am J Med 1978;64(6):998–1004.CrossRefGoogle ScholarPubMed
Mathai, SC, Hummers, LK, Champion, HC, et al. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: Impact of interstitial lung disease. Arthritis Rheum 2009;60(2):569–77.CrossRefGoogle ScholarPubMed
Schachna, L, Wigley, FM, Chang, B, et al. Age and risk of pulmonary arterial hypertension in scleroderma. Chest 2003;124(6):2098–104.CrossRefGoogle ScholarPubMed
Steen, V, Medsger, TA. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 2003;48(2):516–22.CrossRefGoogle ScholarPubMed
Hachulla, E, Gressin, V, Guillevin, L, et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 2005;52(12):3792–800.CrossRefGoogle ScholarPubMed
Mukerjee, D, St George, D, Knight, C, et al. Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology (Oxford) 2004;43(4):461–6.CrossRefGoogle ScholarPubMed
Sun, XG, Hansen, JE, Oudiz, RJ, Wasserman, K.Pulmonary function in primary pulmonary hypertension. J Am Coll Cardiol 2003;41(6):1028–35.CrossRefGoogle ScholarPubMed
Fisher, MR, Mathai, SC, Champion, HC, et al. Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. Arthritis Rheum 2006;54(9):3043–50.CrossRefGoogle ScholarPubMed
Kawut, SM, Taichman, DB, Archer-Chicko, CL, Palevsky, HI, Kimmel, SE.Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. Chest 2003;123(2):344–50.CrossRefGoogle ScholarPubMed
Badesch, DB, Tapson, VF, McGoon, MD, et al. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial. Ann Intern Med 2000;132(6):425–34.CrossRefGoogle ScholarPubMed
Badesch, DB, Hill, NS, Burgess, G, et al. Sildenafil for pulmonary arterial hypertension associated with connective tissue disease. J Rheumatol 2007;34(12):2417–22.Google ScholarPubMed
Girgis, RE, Mathai, SC, Krishnan, JA, Wigley, FM, Hassoun, PM.Long-term outcome of bosentan treatment in idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with the scleroderma spectrum of diseases. J Heart Lung Transplant 2005;24(10):1626–31.CrossRefGoogle ScholarPubMed
Mathai, SC, Girgis, RE, Fisher, MR, et al. Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension. Eur Respir J 2007;29(3):469–75.CrossRefGoogle ScholarPubMed
Condliffe, R, Kiely, DG, Peacock, AJ, et al. Connective tissue disease associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med 2009;179:151–7.CrossRefGoogle ScholarPubMed
al Sabbagh, MR, Steen, VD, Zee, BC, et al. Pulmonary arterial histology and morphometry in systemic sclerosis: a case-control autopsy study. J Rheumatol 1989;16(8):1038–42.Google ScholarPubMed
Yousem, SA.The pulmonary pathologic manifestations of the CREST syndrome. Hum Pathol 1990;21(5):467–74.CrossRefGoogle ScholarPubMed
Morassut, PA, Walley, VM, Smith, CD.Pulmonary veno-occlusive disease and the CREST variant of scleroderma. Can J Cardiol 1992;8(10):1055–8.Google ScholarPubMed
Humbert, M, Sanchez, O, Fartoukh, M, et al. Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study. Eur Respir J 1999;13(6):1351–6.CrossRefGoogle ScholarPubMed
Preston, IR, Klinger, JR, Houtchens, J, et al. Pulmonary edema caused by inhaled nitric oxide therapy in two patients with pulmonary hypertension associated with the CREST syndrome. Chest 2002;121(2):656–9.CrossRefGoogle ScholarPubMed
Bertoli, AM, Vila, LM, Apte, M, et al. Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage. Lupus 2007;16(6):410–7.CrossRefGoogle Scholar
Simonson, JS, Schiller, NB, Petri, M, Hellmann, DB.Pulmonary hypertension in systemic lupus erythematosus. J Rheumatol 1989;16(7):918–25.Google ScholarPubMed
Hodson, P, Klemp, P, Meyers, OL.Pulmonary hypertension in systemic lupus erythematosus: a report of four cases. Clin Exp Rheumatol 1983;1(3):241–5.Google ScholarPubMed
Kasparian, A, Floros, A, Gialafos, E, et al. Raynaud's phenomenon is correlated with elevated systolic pulmonary arterial pressure in patients with systemic lupus erythematosus. Lupus 2007;16(7):505–8.CrossRefGoogle ScholarPubMed
Callejas-Rubio, JL, Lopez-Perez, L, Moreno-Escobar, E, Ortego-Centeno, N.Raynaud's phenomenon and pulmonary arterial hypertension. Lupus 2008;17(4):355.CrossRefGoogle ScholarPubMed
Hennigan, S, Channick, RN, Silverman, GJ.Rituximab treatment of pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report. Lupus 2008;17(8):754–6.CrossRefGoogle ScholarPubMed
Wilson, L, Tomita, T, Braniecki, M.Fatal pulmonary hypertension in identical twins with systemic lupus erythematosus. Hum Pathol 1991;22(3):295–7.CrossRefGoogle ScholarPubMed
Fayemi, AO.Pulmonary vascular disease in systemic lupus erythematosus. Am J Clin Pathol 1976;65(3):284–90.CrossRefGoogle ScholarPubMed
Yokoi, T, Tomita, Y, Fukaya, M, et al. Pulmonary hypertension associated with systemic lupus erythematosus: predominantly thrombotic arteriopathy accompanied by plexiform lesions. Arch Pathol Lab Med 1998;122(5):467–70.Google ScholarPubMed
Roncoroni, AJ, Alvarez, C, Molinas, F.Plexogenic arteriopathy associated with pulmonary vasculitis in systemic lupus erythematosus. Respiration 1992;59(1):52–6.CrossRefGoogle ScholarPubMed
Kanemoto, N, Sato, M, Moriuchi, J, et al. An autopsied case of systemic lupus erythematosus with pulmonary hypertension – a case report. Angiology 1988;39(2):187–92.CrossRefGoogle ScholarPubMed
Samet, P, Bernstein, WH.Loss of reactivity of the pulmonary vascular bed in primary pulmonary hypertension. Am Heart J 1963;66:197–9.CrossRefGoogle ScholarPubMed
Fernandez-Alonso, J, Zulueta, T, Reyes-Ramirez, JR, Castillo-Palma, MJ, Sanchez-Roman, J.Pulmonary capillary hemangiomatosis as cause of pulmonary hypertension in a young woman with systemic lupus erythematosus. J Rheumatol 1999;26(1):231–3.Google Scholar
Srock, K, Kerr, LD, Poon, M, Fallon, JT.Refractory pulmonary hypertension in a lupus patient with occult pulmonary vasculitis. J Clin Rheumatol 2003;9(4):263–6.CrossRefGoogle Scholar
Yutani, C, Imakita, M, Ishibashi-Ueda, H, et al. Pulmonary thromboembolic hypertension in systemic lupus erythematosus with lupus anticoagulant: histopathological analysis of localization and distribution of thromboemboli in pulmonary vasculature. Intern Med 1995;34(10):1030–4.CrossRefGoogle ScholarPubMed
Ryu, JH, Krowka, MJ, Pellikka, PA, Swanson, KL, McGoon, MD.Pulmonary hypertension in patients with interstitial lung diseases. Mayo Clin Proc 2007;82(3):342–50.CrossRefGoogle ScholarPubMed
Behr, J, Ryu, JH.Pulmonary hypertension in interstitial lung disease. Eur Respir J 2008;31(6):1357–67.CrossRefGoogle ScholarPubMed
Handa, T, Nagai, S, Miki, S, et al. Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis. Chest 2006;129(5):1246–52.CrossRefGoogle ScholarPubMed
Shigemitsu, H, Nagai, S, Sharma, OP.Pulmonary hypertension and granulomatous vasculitis in sarcoidosis. Curr Opin Pulm Med 2007;13(5):434–8.CrossRefGoogle ScholarPubMed
Hopkins, N, McLoughlin, P.The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis?J Anat 2002;201(4):335–48.CrossRefGoogle ScholarPubMed
Nunes, H, Humbert, M, Capron, F, et al. Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis. Thorax 2006;61(1):68–74.CrossRefGoogle ScholarPubMed
Smith, LJ, Lawrence, JB, Katzenstein, AA.Vascular sarcoidosis: a rare cause of pulmonary hypertension. Am J Med Sci 1983;285(1):38–44.CrossRefGoogle ScholarPubMed
Judd, PA, Finnegan, P, Curran, RC.Pulmonary sarcoidosis: a clinico-pathological study. J Pathol 1975;115(4):191–8.CrossRefGoogle ScholarPubMed
Uzun, O, Erkan, L, Akpolat, I, et al. Pulmonary involvement in Behçet's disease. Respiration 2008;75(3):310–21.CrossRefGoogle ScholarPubMed
Kasuga, A, Mandai, Y, Katsuno, T, et al. Pulmonary complications resembling Wegener's granulomatosis in ulcerative colitis with elevated proteinase-3 anti-neutrophil cytoplasmic antibody. Intern Med 2008;47(13):1211–4.CrossRefGoogle ScholarPubMed
Gal, AA, Velasquez, A.Antineutrophil cytoplasmic autoantibody in the absence of Wegener's granulomatosis or microscopic polyangiitis: implications for the surgical pathologist. Mod Pathol 2002;15(3):197–204.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×